Performance  ||| S:0 E:12 ||| NN
of  ||| S:12 E:15 ||| IN
mammography  ||| S:15 E:27 ||| NN
and  ||| S:27 E:31 ||| CC
Papanicolaou  ||| S:31 E:44 ||| NNP
among  ||| S:44 E:50 ||| IN
rural  ||| S:50 E:56 ||| JJ
women  ||| S:56 E:62 ||| NNS
in  ||| S:62 E:65 ||| IN
Mexico  ||| S:65 E:72 ||| NNP
To  ||| S:72 E:75 ||| TO
analyze  ||| S:75 E:83 ||| VB
the  ||| S:83 E:87 ||| DT
frequency  ||| S:87 E:97 ||| NN
of  ||| S:97 E:100 ||| IN
reporting  ||| S:100 E:110 ||| VBG
a  ||| S:110 E:112 ||| DT
recently  ||| S:112 E:121 ||| RB
conducted  ||| S:121 E:131 ||| VBN
mammogram  ||| S:131 E:141 ||| NNS
and ||| S:141 E:144 ||| CC
/ ||| S:144 E:145 ||| NNP
or  ||| S:145 E:148 ||| CC
pap  ||| S:148 E:152 ||| JJ
smear  ||| S:152 E:158 ||| NN
and  ||| S:158 E:162 ||| CC
follow-up  ||| S:162 E:172 ||| JJ
of  ||| S:172 E:175 ||| IN
abnormal  ||| S:175 E:184 ||| JJ
findings  ||| S:184 E:193 ||| NNS
among  ||| S:193 E:199 ||| IN
rural  ||| S:199 E:205 ||| JJ
poor  ||| S:205 E:210 ||| JJ
women  ||| S:210 E:216 ||| NNS
in  ||| S:216 E:219 ||| IN
Mexico ||| S:219 E:225 ||| NNP
.  ||| S:225 E:227 ||| .
We  ||| S:227 E:230 ||| PRP
performed  ||| S:230 E:240 ||| VBD
a  ||| S:240 E:242 ||| DT
cross-sectional  ||| S:242 E:258 ||| JJ
analysis  ||| S:258 E:267 ||| NN
using  ||| S:267 E:273 ||| VBG
data  ||| S:273 E:278 ||| NNS
collected  ||| S:278 E:288 ||| VBN
in  ||| S:288 E:291 ||| IN
the  ||| S:291 E:295 ||| DT
ENCEL  ||| S:295 E:301 ||| NNP
2007  ||| S:301 E:306 ||| CD
-  ||| S:306 E:308 ||| :
Oportunidades  ||| S:308 E:322 ||| NNP
survey  ||| S:322 E:329 ||| NN
carried  ||| S:329 E:337 ||| VBD
out  ||| S:337 E:341 ||| RP
between  ||| S:341 E:349 ||| IN
July  ||| S:349 E:354 ||| NNP
-  ||| S:354 E:356 ||| :
November ||| S:356 E:364 ||| NNP
,  ||| S:364 E:366 ||| ,
2007 ||| S:366 E:370 ||| CD
.  ||| S:370 E:372 ||| .
We  ||| S:372 E:375 ||| PRP
used  ||| S:375 E:380 ||| VBD
multilevel  ||| S:380 E:391 ||| JJ
logistic  ||| S:391 E:400 ||| JJ
regression  ||| S:400 E:411 ||| NN
to  ||| S:411 E:414 ||| TO
model  ||| S:414 E:420 ||| VB
the  ||| S:420 E:424 ||| DT
use  ||| S:424 E:428 ||| NN
of  ||| S:428 E:431 ||| IN
mammography  ||| S:431 E:443 ||| NN
and  ||| S:443 E:447 ||| CC
pap  ||| S:447 E:451 ||| JJ
smears ||| S:451 E:457 ||| NN
.  ||| S:457 E:459 ||| .
We  ||| S:459 E:462 ||| PRP
found  ||| S:462 E:468 ||| VBD
a  ||| S:468 E:470 ||| DT
low  ||| S:470 E:474 ||| JJ
frequency  ||| S:474 E:484 ||| NN
of  ||| S:484 E:487 ||| IN
reported  ||| S:487 E:496 ||| VBN
recent  ||| S:496 E:503 ||| JJ
mammogram  ||| S:503 E:513 ||| NN
among  ||| S:513 E:519 ||| IN
the  ||| S:519 E:523 ||| DT
rural  ||| S:523 E:529 ||| JJ
poor  ||| S:529 E:534 ||| JJ
from  ||| S:534 E:539 ||| IN
30-39  ||| S:539 E:545 ||| CD
years  ||| S:545 E:551 ||| NNS
old  ||| S:551 E:555 ||| JJ
( ||| S:555 E:556 ||| -LRB-
12 ||| S:556 E:558 ||| CD
% ||| S:558 E:559 ||| NN
)  ||| S:559 E:561 ||| -RRB-
and  ||| S:561 E:565 ||| CC
40-49  ||| S:565 E:571 ||| CD
years  ||| S:571 E:577 ||| NNS
old  ||| S:577 E:581 ||| JJ
( ||| S:581 E:582 ||| -LRB-
16 ||| S:582 E:584 ||| CD
% ||| S:584 E:585 ||| NN
)  ||| S:585 E:587 ||| -RRB-
and  ||| S:587 E:591 ||| CC
a  ||| S:591 E:593 ||| DT
low  ||| S:593 E:597 ||| JJ
frequency  ||| S:597 E:607 ||| NN
of  ||| S:607 E:610 ||| IN
reported  ||| S:610 E:619 ||| VBN
medical  ||| S:619 E:627 ||| JJ
follow-up  ||| S:627 E:637 ||| NN
of  ||| S:637 E:640 ||| IN
abnormal  ||| S:640 E:649 ||| JJ
findings  ||| S:649 E:658 ||| NNS
( ||| S:658 E:659 ||| -LRB-
60 ||| S:659 E:661 ||| CD
% ||| S:661 E:662 ||| NN
) ||| S:662 E:663 ||| -RRB-
,  ||| S:663 E:665 ||| ,
particularly  ||| S:665 E:678 ||| RB
among  ||| S:678 E:684 ||| IN
women  ||| S:684 E:690 ||| NNS
at  ||| S:690 E:693 ||| IN
higher  ||| S:693 E:700 ||| JJR
risk  ||| S:700 E:705 ||| NN
because  ||| S:705 E:713 ||| IN
of  ||| S:713 E:716 ||| IN
age  ||| S:716 E:720 ||| NN
or  ||| S:720 E:723 ||| CC
abnormal  ||| S:723 E:732 ||| JJ
findings ||| S:732 E:740 ||| NNS
.  ||| S:740 E:742 ||| .
These  ||| S:742 E:748 ||| DT
findings  ||| S:748 E:757 ||| NNS
were  ||| S:757 E:762 ||| VBD
associated  ||| S:762 E:773 ||| VBN
with  ||| S:773 E:778 ||| IN
a  ||| S:778 E:780 ||| DT
lack  ||| S:780 E:785 ||| NN
of  ||| S:785 E:788 ||| IN
availability  ||| S:788 E:801 ||| NN
of  ||| S:801 E:804 ||| IN
medical  ||| S:804 E:812 ||| JJ
resources  ||| S:812 E:822 ||| NNS
and  ||| S:822 E:826 ||| CC
being  ||| S:826 E:832 ||| VBG
of  ||| S:832 E:835 ||| IN
indigenous  ||| S:835 E:846 ||| JJ
origin ||| S:846 E:852 ||| NN
.  ||| S:852 E:854 ||| .
It  ||| S:854 E:857 ||| PRP
is  ||| S:857 E:860 ||| VBZ
fundamental  ||| S:860 E:872 ||| JJ
to  ||| S:872 E:875 ||| TO
strengthen  ||| S:875 E:886 ||| VB
both  ||| S:886 E:891 ||| DT
access  ||| S:891 E:898 ||| NN
to  ||| S:898 E:901 ||| TO
and  ||| S:901 E:905 ||| CC
follow-up  ||| S:905 E:915 ||| JJ
of  ||| S:915 E:918 ||| IN
mammography  ||| S:918 E:930 ||| NN
and  ||| S:930 E:934 ||| CC
papsmears ||| S:934 E:943 ||| NN
,  ||| S:943 E:945 ||| ,
particularly  ||| S:945 E:958 ||| RB
among  ||| S:958 E:964 ||| IN
high-risk  ||| S:964 E:974 ||| JJ
rural  ||| S:974 E:980 ||| JJ
women  ||| S:980 E:986 ||| NNS
in  ||| S:986 E:989 ||| IN
order  ||| S:989 E:995 ||| NN
to  ||| S:995 E:998 ||| TO
reduce  ||| S:998 E:1005 ||| VB
the  ||| S:1005 E:1009 ||| DT
level  ||| S:1009 E:1015 ||| NN
of  ||| S:1015 E:1018 ||| IN
mortality  ||| S:1018 E:1028 ||| NN
associated  ||| S:1028 E:1039 ||| VBN
with  ||| S:1039 E:1044 ||| IN
breast  ||| S:1044 E:1051 ||| NN
and  ||| S:1051 E:1055 ||| CC
cervical-uterine  ||| S:1055 E:1072 ||| JJ
cancer ||| S:1072 E:1078 ||| NN
.  ||| S:1078 E:1080 ||| .
